Kidney Cancer Trial, Recruiting (NCT07299357)

Kidney Cancer Trial, Recruiting NCT07299357 Sponsor: Istituto Clinico Humanitas Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07299357 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You must be well enough to carry out some daily activities (not completely disabled by illness) (confirm with trial site)
Your kidney cancer must have been confirmed by a tissue sample (biopsy or similar test)
Your tumor must be in one single spot in the kidney and measure no more than 7 cm across (roughly the size of a small apple)
You must either be considered too unwell for surgery, be at high risk of serious complications from surgery, or have chosen not to have surgery
Your cancer must not have spread to other parts of the body
You must be willing and able to give written consent to take part

Who may not be able to join:

Your kidneys are not working well enough (based on a blood test measuring kidney function) (confirm with trial site)
You have previously had radiotherapy treatment in the same area of the body
You have previously received drug treatments (such as chemotherapy or targeted therapy) for your kidney cancer
Your tumor measures more than 7 cm across
Your cancer has spread to other parts of the body
Your doctors estimate you have less than 3 months to live

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 0282247454

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07299357

Sponsor: Istituto Clinico Humanitas

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: +39 0282247454

More information: https://clinicaltrials.gov/study/NCT07299357

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You must be well enough to carry out some daily activities (not completely disabled by illness) (confirm with trial site)
Your kidney cancer must have been confirmed by a tissue sample (biopsy or similar test)
Your tumor must be in one single spot in the kidney and measure no more than 7 cm across (roughly the size of a small apple)
You must either be considered too unwell for surgery, be at high risk of serious complications from surgery, or have chosen not to have surgery
Your cancer must not have spread to other parts of the body
You must be willing and able to give written consent to take part

Who may not be able to join:

Your kidneys are not working well enough (based on a blood test measuring kidney function) (confirm with trial site)
You have previously had radiotherapy treatment in the same area of the body
You have previously received drug treatments (such as chemotherapy or targeted therapy) for your kidney cancer
Your tumor measures more than 7 cm across
Your cancer has spread to other parts of the body
Your doctors estimate you have less than 3 months to live

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istituto Clinico Humanitas

Registry

ClinicalTrials.gov

Start date

1 January 2026

Est. completion

1 December 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

evaluate LC of treated lesions at 1 year

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov